Developing Biomedical products with French Company to Combat Pandemic Covid -19 and Post Covid-19 era.

Developing Biomedical products with French Company to Combat Pandemic Covid -19 and Post Covid-19 era.

  Working Together Developing Biomedical Product(s) to Combat COVID 19. Ruhvenile Biomedical, India, and RNA SMART HEALTH, Paris, France, have been collaborating to develop RNA-based therapeutics to combat COVID-19 and future infectious pandemic. This collaboration aims to provide engineered antibodies

Developing Novel Therapeutics with National and International Research Institutes to Combat COVID-19 and Future Pandemics.

Developing Novel Therapeutics with National and International Research Institutes to Combat COVID-19 and Future Pandemics.

  Multidisciplinary, collaborative work with International Centre for Genetic Engineering and Biotechnology (New Delhi, India, and Trieste, Italy) A team, comprising Arockiasamy Arulandu, Sujatha Sunil, and Alessandro Marcello, together with Ruhvenile Biomedical OPC Pvt. Ltd., India, working to develop novel therapeutics against COVID-19, through

Indigenous antimicrobial product to protect front line health workers and stop transmission developed by Ruhvenile Biomedical

Indigenous antimicrobial product to protect front line health workers and stop transmission developed by Ruhvenile Biomedical

  In-house, indigenous antimicrobia compound-discovered and developed. For the last four years, M/s Ruhvenile Biomedical OPC Private Limited., based in New Delhi, India, has been extensively screening small organic compounds to identify non-toxic, non-ionic candidate compounds with validated enveloped-viruses deactivation